Bora CDMO Bora CDMO

X

CAS 1441670-89-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1441670-89-8
Also known as: 1441670-89-8, Tert-butyl (6s)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate, (6s)-6-[5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester, (6s)-tert-butyl-6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate, (s)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro(2.4)heptane-5-carboxylate, (s)-tert-butyl6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate
Molecular Formula
C27H26BrF2N3O2
Molecular Weight
542.4  g/mol
InChI Key
CZEZIZZCMWUQHO-QFIPXVFZSA-N

1 2D Structure

CAS 1441670-89-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
tert-butyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
2.1.2 InChI
InChI=1S/C27H26BrF2N3O2/c1-25(2,3)35-24(34)33-14-26(8-9-26)12-22(33)23-31-13-21(32-23)15-4-6-17-18-7-5-16(28)11-20(18)27(29,30)19(17)10-15/h4-7,10-11,13,22H,8-9,12,14H2,1-3H3,(H,31,32)/t22-/m0/s1
2.1.3 InChI Key
CZEZIZZCMWUQHO-QFIPXVFZSA-N
2.1.4 Canonical SMILES
CC(C)(C)OC(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)Br
2.1.5 Isomeric SMILES
CC(C)(C)OC(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)Br
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1441670-89-8

2. Tert-butyl (6s)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate

3. (6s)-6-[5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic Acid 1,1-dimethylethyl Ester

4. (6s)-tert-butyl-6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate

5. (s)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro(2.4)heptane-5-carboxylate

6. (s)-tert-butyl6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate

7. 5-azaspiro[2.4]heptane-5-carboxylic Acid, 6-[5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl]-, 1,1-dimethylethyl Ester, (6s)-

8. Tert-butyl (6s)-6-[5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate

9. Ec 939-899-8

10. Schembl16541579

11. Schembl19232180

12. Amy4178

13. Dtxsid001101609

14. Cs-z0007

15. Mfcd28386931

16. Akos028109756

17. Zinc141371669

18. Ac-28973

19. Ds-19340

20. Tert-butyl (6s)-6-[5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl]-5-azaspiro[2.4]heptane

21. I11541

22. A853036

23. (6s)-t-butyl-6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate

24. (s)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;ledipasvir Intermediate

25. Tert-butyl (s)-6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate

2.3 Create Date
2015-05-06
3 Chemical and Physical Properties
Molecular Weight 542.4 g/mol
Molecular Formula C27H26BrF2N3O2
XLogP35.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass541.11765 g/mol
Monoisotopic Mass541.11765 g/mol
Topological Polar Surface Area58.2 Ų
Heavy Atom Count35
Formal Charge0
Complexity847
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
1129634-44-1
Ledipasvir
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, ...
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, adjacent to SINOPEC Anqing Branch. This industry park has been declared as a national chemical industry park, providing a strong impetus and solid guarantee for the future development of us. As a production base, Anhui Haikang provides sufficient high-quality pharmaceutical and chemical products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
1378387-81-5
Ledipasvir
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, ...
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, adjacent to SINOPEC Anqing Branch. This industry park has been declared as a national chemical industry park, providing a strong impetus and solid guarantee for the future development of us. As a production base, Anhui Haikang provides sufficient high-quality pharmaceutical and chemical products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
291775-59-2
Ledipasvir
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, ...
Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, adjacent to SINOPEC Anqing Branch. This industry park has been declared as a national chemical industry park, providing a strong impetus and solid guarantee for the future development of us. As a production base, Anhui Haikang provides sufficient high-quality pharmaceutical and chemical products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY